Trial Profile
A retrospective study to evaluate safety and efficacy of Mycophenolate Mofetil monotherapy in liver transplant patients with nephrotoxicity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2016
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Liver transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2016 New trial record